Synaptic disruption precedes neuronal death and correlates with clinical features of Alzheimer's disease (AD). The identification of fluid biomarkers of synaptic damage is emerging as a goal for early and accurate diagnosis of the disease.

Synaptic Proteins as Fluid Biomarkers in Alzheimer's Disease: A Systematic Review and Meta-Analysis

Roveta, Fausto
;
Cermelli, Aurora;Boschi, Silvia;Ferrandes, Fabio;Grassini, Alberto;Spina, Margherita;Rubino, Elisa;Vercelli, Alessandro;Rainero, Innocenzo
2022-01-01

Abstract

Synaptic disruption precedes neuronal death and correlates with clinical features of Alzheimer's disease (AD). The identification of fluid biomarkers of synaptic damage is emerging as a goal for early and accurate diagnosis of the disease.
2022
1
13
Alzheimer’s disease; GAP-43; SNAP-25; blood; cerebrospinal fluid; meta-analysis; neurogranin; synaptic dysfunction; synaptotagmin-1; systematic review
Roveta, Fausto; Cermelli, Aurora; Boschi, Silvia; Ferrandes, Fabio; Grassini, Alberto; Marcinnò, Andrea; Spina, Margherita; Rubino, Elisa; Borsello, Tiziana; Vercelli, Alessandro; Rainero, Innocenzo
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1880981
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact